NVO
USDNovo Nordisk A/S Common Stock
$45.700-0.520 (-1.125%)
リアルタイム価格
Healthcare
Drug Manufacturers - General
デンマーク
価格チャート
Loading Chart...
主要指標
市場指標
始値
$46.220
高値
$46.360
安値
$45.570
出来高
37.86M
企業ファンダメンタルズ
時価総額
210.1B
業種
Drug Manufacturers - General
国
Denmark
取引統計
平均出来高
15.16M
取引所
NYQ
通貨
USD
52週レンジ
安値 $45.05現在値 $45.700高値 $112.52
関連ニュース
CNBC
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
もっと見る
CNBC
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
もっと見る
CNBC
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
もっと見る
CNBC
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
もっと見る
関連株式
最新情報を入手
価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。